International Prostate Cancer Update 2016 Archives

Neuroendocrine Prostate Cancer (NEPC): Are We Selecting For It With Our Current Androgen Annihilation?

by Jehonathan H. Pinthus, MD, PhD, FRCSC | Nov 2016

Dr. Jehonathan Pinthus presented at the 26th International Prostate Cancer Update on Friday,...

Cardiovascular Complications of ADT: Reviewing Pre-clincal and Clinical Data and Introducing the RADICAL-PC Trial

by Jehonathan H. Pinthus, MD, PhD, FRCSC | Oct 2016

Dr. Jehonathan Pinthus presented at the 26th International Prostate Cancer Update on Friday,...

Statins, Aspirin, and Metformin (S.A.M.): The Best “Natural” Pill for Patients Concerned about Prostate Cancer

by Mark A. Moyad, MD, MPH | Sep 2016

Dr. Moyad presented at the 26th International Prostate Cancer Update on Friday, January 22, 2016...

Prevention, Screening, and Genomic Markers Panel Discussion

by M. Scott Lucia, MD | Jul 2016

Drs. M. Scott Lucia, E. David Crawford, Gerald L. Andriole, Stacy Loeb, and Omer Kucuk presented...

Active Surveillance at Johns Hopkins – 20 Year Update

by Alan W. Partin, MD, PhD | May 2016

Dr. Alan W. Partin presented at the 26th International Prostate Cancer Update on Thursday, January...

Early Chemotherapy for Metastatic Prostate Cancer

by Daniel P. Petrylak, MD | May 2016

Dr. Petrylak presented at the 26th International Prostate Cancer Update on Friday, January 22,...

Accurate Staging of Prostate Cancer

by Phillip J. Koo, MD | May 2016

Dr. Phillip J. Koo presented “Accurate Staging of Prostate Cancer.”at the 26th...

Radical Prostatectomy: Management of the Primary From Localized to Oligometastatic Disease

by James A. Eastham, MD, FACS | May 2016

Dr. Eastham presented “Radical Prostatectomy: Management of the Primary From Localized to...

The Future of Clinical Research in Private Practice: Alive or Dead?

by Lawrence I. Karsh, MD | May 2016

Dr. Karsh presented at the 26th International Prostate Cancer Update on Saturday, January 23, 2016...

Soy Isoflavones in Prostate Cancer Prevention, Treatment and Survivorship Research

by Omer Kucuk, MD | May 2016

Dr. Kucuk presented at the 26th International Prostate Cancer Update on Thursday, January 21,...

Strategies of Radiotherapy for Intermediate to High-Risk Prostate Cancer

by Daisaku Hirano, MD | May 2016

Dr. Hirano presented at the 26th International Prostate Cancer Update on Thursday, January 21,...

Prostate Biopsy and Targeted Therapy

by Nelson N. Stone, MD | Apr 2016

Dr. Stone presented “Prostate Biopsy and Targeted Therapy” at the 26th International...

International Prostate Cancer Update 2016

Neuroendocrine Prostate Cancer (NEPC): Are We Selecting For It With Our Current Androgen Annihilation?

Cardiovascular Complications of ADT: Reviewing Pre-clincal and Clinical Data and Introducing the RADICAL-PC Trial

Statins, Aspirin, and Metformin (S.A.M.): The Best “Natural” Pill for Patients Concerned about Prostate Cancer

Prevention, Screening, and Genomic Markers Panel Discussion

Active Surveillance at Johns Hopkins – 20 Year Update

Early Chemotherapy for Metastatic Prostate Cancer

Accurate Staging of Prostate Cancer

Radical Prostatectomy: Management of the Primary From Localized to Oligometastatic Disease

The Future of Clinical Research in Private Practice: Alive or Dead?

Soy Isoflavones in Prostate Cancer Prevention, Treatment and Survivorship Research

Strategies of Radiotherapy for Intermediate to High-Risk Prostate Cancer

Prostate Biopsy and Targeted Therapy

Join the GRU Community

You have Successfully Subscribed!

CARDEN JENNINGS PUBLISHING CO., LTD.

INFO

Your GRU

– Account Dashboard
– Your Courses

Recent Updates

Exercise & Wellness